Upfront Payments by Therapeutic Category
Executive SummaryOne way a biotech might choose a therapeutic area of focus is by the value it could extract from a licensee. To get a handle on this value, we ranked the top therapeutic categories by total upfront money paid over the last 12 months, both in terms of equity and straight cash.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.